White Paper

White Paper – Proposed QMSR Expert Analysis (Part 2)

Medicept
by Medicept
1 min read
May 17, 2022

On Feb. 23, 2022, the U.S. FDA published the Draft Proposed Rulemaking for the new “Quality Management System Regulation.” It’s imperative that the entire industry thoroughly understand the new proposal and any nuances. This White Paper is Part 2 of a series of technical analyses to help inform any interested parties.

 
Previous story
← White Paper – Proposed QMSR Expert Analysis (Part 1)
Next story
FDA Proposed Quality Management System Regulation (QMSR): Expert Analysis – Part 2: Understanding Proposed 21 CFR 820.35 – Records White Paper Download →
White Paper – Proposed QMSR Expert Analysis (Part 1)
FDA department sign
White Paper

White Paper – Proposed QMSR Expert Analysis (Part 1)

March 4, 2022 1 min read
White Paper – FDA Guidance Documents for De Novo Classification Requests
road to successful De Novo Classification Requests
White Paper

White Paper – FDA Guidance Documents for De Novo Classification Requests

June 29, 2022 1 min read
FDA Proposed Quality Management System Regulation (QMSR): Expert Analysis – Part 1: Understanding Definitions White Paper Download
FDA proposed quality management system regulation (QMSR) expert analysis part 1
White Paper

FDA Proposed Quality Management System Regulation (QMSR): Expert Analysis – Part 1: Understanding Definitions White Paper Download

March 2, 2022 1 min read

Patients Are Waiting.

Every submission, study, inspection, and commercialization decision moves a patient closer to the technology they're waiting for. Partner with Medicept to navigate every milestone with clarity, continuity, and confidence.

Talk to an Expert